Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Mesothelioma Surgery with Organ Removal Extends Survival
2 Adam Bass to Lead Precision Cancer Medicine at Columbia University
3 Clinical Investigation Into Antibody With Activity Against SSTR2 and CD3 Moves Forward
4 Chasing Cancer with Jeffrey Drebin, MD, Noopur Raje, MD & Lisa Ray
5 2020 ISGIO Seeks to Simplify Complexities in GI Cancer to Improve Care
6 Radiation Oncology Leaders Bristle Over New Medicare Payment Model
7 Immunotherapy Reaches New Heights in Upper GI Cancer Trials
8 Scott Kopetz, MD, PhD, FACP, Discusses Next Steps for GI Oncology
9 PET molecular imaging helps guide treatment, improves DFS in recurrent prostate cancer
10 Across Cancer Settings, ICIs Continue to Make Deep Inroads
11 IMFINZI® (durvalumab) Approved In The US For Less-Frequent, Fixed-Dose Use
12 Otago scientists win NZSO Roche Translational Cancer Research Fellowship
13 Top NY GI Oncologists Spotlight Groundbreaking Research Efforts
14 Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
15 Karyopharm Reports Positive Phase 3 SEAL Data in Oral Presentation at The Connective Tissue Oncology Society 2020 Annual Meeting
16 COVID-19 Pandemic Creates Teachable Moment for Oncologists in Lung Cancer
17 Top GI Oncologists Share Excitement on 16th Annual ISGIO Conference
18 Talking HER2-Targeted Therapy With Dr. Ajani
19 Hematology/oncology institutions, practices announce faculty promotions, additions
20 RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib
21 Nivolumab Plus Regorafenib Regimen Active in Gastrointestinal Cancers
22 Fam-trastuzumab deruxtecan-nxki improves outcomes in gastric cancer subset
23 What Is a Gastroenterologist?
24 Oncologie, Inc. Announces Collaboration with Moffitt Cancer Center to Advance the Development of Precision Medicine for the Treatment of Gastric and Gastrointestinal Cancers
25 Dr. Kim on Efficacy and Next Steps With Regorafenib/Nivolumab Combo in CRC
26 COVID-19 as a barrier to attending for gastrointestinal endoscopy: weighing up the risks
27 Van Morris, MD, Discusses Novel Therapies for Patients with Colorectal and Anal Cancer
28 Kiniksa Announces US FDA Acceptance of sBLA and Priority Review for Rilonacept in Recurrent Pericarditis
29 RedHill Biopharma Completes Enrollment for COVID-19 US Phase 2 Study with Opaganib
30 Pitt & UPMC Hillman Cancer Center Name New Leader of Surgical Oncology
31 Dr. Smaglo on the Role of Immunotherapy in Advanced Gastric Cancer
32 Model predicts immunotherapy response in colon and GI cancers
33 Black Patients with Cancer, COVID-19 More Likely to Experience Complications, Hospitalization
34 Gum disease linked to higher risk for gastric, esophageal cancers
35 Expert Highlights Importance of Biomarker Testing in Pancreatic Cancer
36 Fox Chase Cancer Center announces faculty appointments
37 Aspirin linked to reduction in risk of several cancers of the digestive tract
38 Pembrolizumab appears promising for certain patients with gastric, gastroesophageal cancer
39 Phase 3 study of three-drug regimen for biliary tract cancer exceeds enrollment goal
40 Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020
41 Addition of cetuximab to chemotherapy shortens OS in advanced colorectal cancer subset
42 Practice patterns of diagnostic upper gastrointestinal endoscopy during the initial COVID-19 outbreak in England
43 Anti-HER2 Agents Explored Further in Gastric, Colorectal, and NSCLC Settings
44 When a Cancer Patient Tests Positive for Covid-19
45 Nosocomial Infections in Gastrointestinal Cancer Patients: Bacterial P | CMAR
46 OncLive® Honors 15 Cancer Care Pioneers
47 Pembrolizumab Shows Durable Response in Advanced Unresectable Anal Cancer
48 C. Kent Osborne steps down as director of Dan L Duncan Comprehensive Cancer Center
49 Your Questions Answered: Biosimilars in GI Cancers
50 OncLive and The Ruesch Center for the Cure of Gastrointestinal Cancers Names the 2020 Honorees of the Luminary Awards in GI Cancers
51 Tabernero Finds New Paths in Gastrointestinal Treatment Landscape
52 Exploring Regorafenib and Nivolumab as Treatment for Colorectal Cancer
53 Liposomal Irinotecan Regimen Pushes Toward Frontline Treatment in Metastatic Pancreatic Cancer
54 Governor Cooper Announces Boards and Commissions Appointments
55 Moffitt Cancer Center names president and CEO
56 Adding bevacizumab to chemotherapy increases resectability of colorectal liver metastases
57 Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
58 Analyzing the ESPAC-5F Trial in Borderline Resectable Pancreatic Cancer
59 Pamela Kunz: “In any other industry, if someone had behavior like that, they would be fired.”
60 Chi-Med Highlights Surufatinib Phase III Results in Neuroendocrine Tumors at ESMO 2020 and Publications in The Lancet Oncology
61 Oncology | Duncan Cancer Center | Baylor Medicine
62 Rivoceranib fails to significantly improve OS in advanced gastric cancer
63 Cleveland Clinic announces several oncology staff appointments
64 Watch-and-wait strategy may be appropriate for certain patients with rectal cancer
65 FDA grants orphan drug designation to OBI-999 for gastric cancer
66 Targeted treatments extend survival in pancreatic cancer
67 Drug Duo Is Promising in Older Patients With Advanced HCC
68 Patients with Gynecologic Cancer May Not be at Increased Risk of COVID-19
69 ONCOLOGY® Welcomes Six Tumor Chairs to Editorial Advisory Board
70 Emotional Distress During the COVID-19 Pandemic: Psycho-Oncology Perspective
71 MSK Announces New Chief of Gastrointestinal Medical Oncology
72 Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective
73 Regorafenib Plus Nivolumab Limits Tumor Growth In Gastric and Colorectal Cancers
74 Regorafenib/Nivolumab Shows Modest Activity in MMR Proficient Advanced Refractory CRC
75 Cathy Eng named co-leader of GI cancer program at Vanderbilt
76 Delayed Radiation Therapy for Prostate Cancer Did Not Impact Overall Survival
77 Black Non-Hispanic Patients Receive Worse Head and Neck Cancer Prognosis
78 Gregory Vidal, MD, PhD, on Treating Patients with HER2+ Breast Cancer During COVID-19
79 Nurse-Led Telephone Triage Decreases Hospitalizations and Cancer Costs
80 Biochemist to lead City of Hope department focused on cancer metabolism, diabetes
81 The role of red blood cell exchange in sickle cell disease in patient with COVID‐19 infection and pulmonary infiltrates
82 Real-World Data Indicate Favorable Efficacy With Nivolumab in Advanced Gastric Cancer
83 Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
84 Sumit K. Subudhi, MD, PhD, on Results from the Phase 2 CheckMate 650 Trial
85 Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials
86 Atezolizumab/Bevacizumab Shows Comparable Activity in Older Patients With Advanced HCC
87 Bevacizumab + Atezolizumab: Survival and Quality-of-Life Benefits in Advanced Liver Cancer Spur Regulatory Approval
88 Cleveland Clinic appoints department chair
89 New cancer treatment: more effective than chemotherapy and no side effects
90 Karen H. Lu, MD, on Genetic Testing From Patients' Living Rooms
91 Christopher R. Flowers, MD, on Disparities in Lymphoma and Myeloma
92 COVID-19 Infects GI Tract, a Possible Route of Viral Transmission
93 Fox Chase Cancer Center creates department of bone marrow transplant, cellular therapies
94 OncMadness: Meet the Blue Ribbon Panel
95 Triplet and Doublet Regimens Outperform Standard of Care on Survival, QoL in BRAF+ CRC
96 Chi-Med Highlights Presentations of Surufatinib at the Upcoming AACR Virtual Annual Meetings
97 MD Anderson, Allogene partner on development of allogeneic CAR T-cell therapies
98 Bruna Pellini, MD, on the Approval of the Guardant360 CDx
99 City of Hope names pathology department chair, lymphoma center associate director
100 Guillermo Garcia-Manero, MD, on Eprenetapopt-Azacytidine Combo in TP53+ MDS